2010 Upcoming Conference Summaries
Alzheimer’s Drug Discovery in New York- NYBA Annual Meeting
April 20, 2010- New York, NY This panel session will include a range of speakers from academia and biotech in New York City who will discuss innovative approaches to drug discovery for Alzheimer’s disease. Programs on cognitive enhancers, tau immunotherapy, neuroimaging technology and small molecule modulation of protein folding will be presented. Conference website
Mitochondrial Function as a Therapeutic Target for Alzheimer’s Disease
May 13, 2010- New York, NY A one-day symposium on mitochondria as a target for Alzheimer’s drug discovery. The symposium will explore the role of mitochondria in Alzheimer’s disease pathogenesis and will feature presentations on therapeutic programs targeting mitochondrial pathways for Alzheimer’s. ADDF co-hosts the meeting with the New York Academy of Sciences. Conference website
ADDF Media Partnership for 2nd Annual Drug Development for Neurodegeneration
May 18-19, 2010- Boston, MA ADDF is a silver media partner for the 2nd DDND conference, which focuses on advances in drug development for neurodegenerative diseases and expediting discovery through novel compounds and sound clinical trials. Conference site
11th International Alzheimer’s Disease Drug Discovery Conference
September 26-28, 2010- Jersey City, NJ A two-day global conference for research scientists to engage in discussion and cross-fertilization of ideas focusing on Alzheimer’s drug discovery research. The conference objectives are to: (1) discuss scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias; (2) increase networking opportunities for scientists to share information and resources; and (3) publish a post-meeting report in a scientific journal. The meeting attracts 150+ participants from around the world. Conference Site Coming Soon
Filling the Pipeline: Novel Targets for Alzheimer’s Drug Discovery
November 3, 2010- Toulouse, France A one-day meeting focusing on European biotechnology companies conducting early-stage high risk research for Alzheimer’s disease that complement approaches in advanced clinical trials. This is a satellite meeting to be held in conjunction with the 3rd Clinical Trials on Alzheimer’s Disease conference. Conference website
2011 Upcoming Conference Summaries
6th International Pharmacoeconomic Conference on Alzheimer’s Disease
January 20-21, 2011- London, U.K. IPECAD is the only conference that exclusively addresses issues related to the economic evaluation of drug treatments for Alzheimer’s disease, bringing together leading experts and opinion leaders from the academia, regulatory bodies and the pharmaceutical industry. ADDF co-hosts the meeting with the Karolinska Institutet. Conference Site Coming Soon
All Alzheimer’s Drug Discovery & Drug Discovery for Neurodegeneration Conferences